15 Apr 2026Open access1cites
Neuroprotective effects of rutin, sodium selenite, and rutin-conjugated selenium nanoparticles in a social isolation modelPublisher siteFrontiers in Pharmacology, Selenium in Biological Systems
UniversitiesTriveena M. Ramsis
Active, last published 2026
In synthesis and biological activity
Triveena M.
Ramsis
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Sinai University
Claim Your Profile7
H-index
159
Citations
Triveena has not officially claimed their profile. If you are Triveena, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
riveena M. Ramsis is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Triveena's work has been cited 159 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×5Inflammatory mediators and NSAID effects×4Synthesis and Biological Evaluation×4Computational Drug Discovery Methods×3Cholinesterase and Neurodegenerative Diseases×3
04 · Where I am
Affiliations
Affiliation on published researchSinai UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works6 Jan 2026Open access1cites
Bridging the gap with amide linkers: rational design, synthesis, and multi-target evaluation of sulfonamide/acetamide-NSAID hybrids as dual COX-2/5-LOX inhibitorsPublisher siteFuture Medicinal Chemistry, Inflammatory mediators and NSAID effects
2 Jan 2026Open access2cites
From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer’s agents with <i>in vivo</i> / <i>in vitro</i> validation and <i>in silico</i> insightsPublisher siteJournal of Enzyme Inhibition and Medicinal Chemistry, Synthesis and biological activity
1 Jan 2026Open access
A structural blueprint for antibacterial discovery: microwave- and ultrasound-assisted synthesis of pyrrolidine-fused quinoxalines as novel inhibitors of DNA gyrase and biofilmPublisher siteRSC Advances, Synthesis and Biological Evaluation
3 Oct 2025Open access6cites
Flufenamic acid-based sulfonohydrazide and acetamide derivatives NSAI as inhibitors of multi-targets COX-1/COX-2/5-LOX: design, synthesis, in silico ADMET and binding mode studiesPublisher siteBMC Chemistry, Synthesis and biological activity
17 Aug 2025Open access6cites
Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer’s Disease: In Vivo, In Vitro, Histopathological, and Docking StudiesPublisher sitePharmaceuticals, Cholinesterase and Neurodegenerative Diseases
28 Jan 20254cites
Insulinotropic and anti-obesity properties of ethno-medicinal plants: pharmacology-based and <i>in-silico</i> predictionsPublisher siteNatural Product Research, Natural Antidiabetic Agents Studies
27 Jan 20258cites
Novel Pyrrolidine-bearing quinoxaline inhibitors of DNA Gyrase, RNA polymerase and spike glycoproteinPublisher siteBioorganic Chemistry, Synthesis and Biological Evaluation
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Triveena?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you